Keywords
Severe pneumonia
Expression level
Disease severity
Correlation
Submitted : 2025-06-08
Accepted : 2025-06-23
Published : 2025-07-08
Abstract
Objective: To investigate the expression level of interleukin-17D (IL-17D) in the serum of patients with severe pneumonia and its correlation with disease severity. Methods: This study included 50 patients with severe pneumonia who were diagnosed and treated in the hospital from May 2024 to May 2025. The expression level of IL-17D in the serum of all patients was recorded. Patients were divided into severe and mild groups based on their disease severity. Gender, age, disease duration, presence of fever, atelectasis, pneumothorax, interleukin-2 (IL-2), interleukin-4 (IL-4), interleukin-6 (IL-6), and interleukin-17D were selected as independent variables. Statistical software SPSS 22.00 was used for univariate analysis, and variables with statistical significance in the univariate analysis were included in a multivariate logistic regression analysis to determine the correlation between IL-17D and the severity of severe pneumonia. Results: The results of this study showed that the level of IL-17D in patients with severe pneumonia was significantly higher than the normal threshold. Univariate analysis indicated that atelectasis, IL-2, IL-6, and IL-17D were statistically significant (P < 0.05) and could be considered as influencing factors for the severity of severe pneumonia. Multivariate logistic regression analysis revealed that atelectasis (OR=2.141, 95% CI: 1.684–2.391), IL-2 (OR=2.884, 95% CI: 2.240–3.614), IL-6 (OR=2.571, 95% CI: 2.190–2.943), and IL-17D (OR=2.416, 95% CI: 2.093–2.735) were positively correlated with the severity of severe pneumonia. Conclusion: The expression level of IL-17D in the serum of patients with severe pneumonia is higher than the normal threshold and is positively correlated with disease severity.
References
Li X, Ye L, Zhao L, et al., 2024, Etiology of Multidrug-Resistant Bacterial Infections in Patients with Severe Pneumonia and Diagnostic Value of NETs, IL-17, and TGF-β. Chinese Journal of Nosocomiology, 34(7): 973–977.
Cai JY, Tao XF, Wang GW, et al., 2024, Expression Levels of Serum IL-17, IL-12P70, and CD64 in Patients with Severe Pneumonia and Their Relationship with Prognosis. Chinese Journal of Nosocomiology, 34(16): 2452–2456.
Duan Y, Ou Y, Li J, et al., 2025, Serum Cytokine Levels in Children with Community-Acquired Pneumonia Caused by Different Respiratory Pathogens. Italian Journal of Pediatrics, 51(1): 147–147.
Guo R, Wang W, Liu HF, 2024, The Effect of Serum Interleukin-17A and Interleukin-10 on the Prognosis of Patients with Emergency Severe Pneumonia. Chinese Journal of Emergency Medicine, 44(12): 1079–1084.
Deng AB, Li XM, Song J, et al., 2024, Changes and Clinical Significance of Serum Procalcitonin, IL-17, and sTREM-1 Levels in Adult Patients with Severe Pneumonia. Journal of Clinical and Experimental Medicine, 23(14): 1498–1501.
Yan L, Zeqin F, Yinfu H, et al., 2023, Interleukin-18-Primed Human Umbilical Cord-Mesenchymal Stem Cells Achieve Superior Therapeutic Efficacy for Severe Viral Pneumonia via Enhancing T-Cell Immunosuppression. Cell Death & Disease, 14(1): 66–66.
Chen M, Xu H, Wang Q, et al., 2017, Changes and Significance of IL-6, IL-10, IL-17, and HMGB1 Levels in Bronchoalveolar Lavage Fluid of Children with Severe Pneumonia. Chinese Journal of Emergency Medicine, 37(z1): 171–172.
Deng HT, Ran YP, Ma QH, et al., 2022, Efficacy of Immune-Enhancing Enteral Nutrition as Adjunctive Therapy for Elderly Patients with Severe Pneumonia and Changes in HMGB1/IL-17/IL-23. Chinese Journal of Nosocomiology, 32(9): 1299–1302.
Peng HL, Wang CG, Zhou TZ, et al., 2023, Expression of Serum IL-17A, S100A8, and S100A9 in Children with Severe Mycoplasma Pneumoniae Pneumonia and Their Significance in Prognosis. International Journal of Laboratory Medicine, 44(24): 3010–3015.
Li MX, Liu Q, Peng HX, et al., 2024, Effects of Salidroside on Apoptosis of Lung Vascular Endothelial Cells and Expression of IL-23 and Th17 in Rats with Severe Pneumonia via the NF-κB/Bcl-2 Signaling Pathway. Shaanxi Journal of Traditional Chinese Medicine, 45(6): 745–750.